Cancer Health Equity Career Development Program

$418,094T32FY2025CANIH

University Of Illinois At Chicago, Chicago IL

Investigators

Linked publications & trials

Paper 39471492 Paper 39417824 Paper 39363144 Paper 38846908 Paper 38453027 Paper 38398828 Paper 37677809 Paper 37612243 Paper 37571270 Paper 37495653 Paper 37430415 Paper 37319166 Paper 37302410 Paper 37149439 Paper 37126157 Paper 37081154 Paper 37046780 Paper 36976634 Paper 36914996 Paper 36914720 Paper 36827280 Paper 36793105 Paper 36689734 Paper 36657045 Paper 36625531 Paper 36583638 Paper 36580834 Paper 36580236 Paper 36473628 Paper 36419021 Paper 36319597 Paper 36268648 Paper 36162099 Paper 36162097 Paper 36162089 Paper 36088143 Paper 36048735 Paper 36044628 Paper 35941401 Paper 35819993 Paper 35679128 Paper 35440042 Paper 35272263 Paper 35103491 Paper 35057462 Paper 34896543 Paper 34706928 Paper 34313460 Paper 34306242 Paper 34223908 Paper 34188144 Paper 34041942 Paper 33665063 Paper 33630156 Paper 33598698 Paper 33430766 Paper 32803725 Paper 32695922 Paper 32528823 Paper 32490700 Paper 31870912 Paper 31861788 Paper 31639197 Paper 31406947 Paper 31342166 Paper 31177942 Paper 31123871 Paper 30982113 Paper 30929011 Paper 30775929 Paper 30740866 Paper 30737348 Paper 30027480 Paper 29898891 Paper 29718296 Paper 29531106 Paper 29528252 Paper 29465252 Paper 29411234 Paper 28822065

Abstract

This renewal application for Years 31-35 of the University of Illinois at Chicagoâs T32 application is designed to support a scientific environment to prepare the next generation of cancer researchers through cancer educational programming, mentored research training, and career and leadership development for predoctoral and postdoctoral trainees. Over the past 30 years, the University of Illinois at Chicagoâs National Cancer Institute (NCI) T32 program has prepared trainees to focus on the transdisciplinary skills needed to address cancer prevention, control, and survivorship. This renewal application will continue to train and advance cancer educational training and research by supporting pre and postdoctoral trainees to become independent scientists. Since our initial funding under the R25T mechanism in 1992 (transitioned to T32 in 2018), our T32 has received continuous NCI support resulting in a significant contribution to the cancer research workforce. Of the 18 completed predoctoral trainees, 72% went on to postdoctoral fellowships and of the 14 completed postdoctoral trainees, 71 % accepted academic positions following the training. This renewal application is in response to PA-20-142. Aim 1. To continue to recruit and train pre and postdoctoral trainees who are dedicated to academic careers in cancer prevention, control, and survivorship. Aim 2. To continue to provide a rigorous skills training program with a comprehensive curriculum; transdisciplinary seminars; leadership certificate programs; experiential learning with scientific writing; and experiences in basic, clinical, and applied settings. Aim 3. To prepare trainees to develop, implement, and disseminate independent research by providing strong mentorship and scientific specialization in cancer prevention, control, and survivorship. Aim 4. To continue to provide plans for Instruction in the Responsible Conduct of Research and in Methods for Enhancing Reproducibility in alignment with NIH policies. Aim 5. To continue to provide ongoing evaluation of our training program to ensure that it is meeting educational, mentored research training, and career and leadership development metrics.

View original record on NIH RePORTER →